Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD44 SNPrs187115: A Novel Biomarker Signature that Predicts Survival in Resectable Pancreatic Ductal Adenocarcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Dec 2016

Stracquadanio Giovanni, Vrugt Bart, Flury Renata, Schraml Peter, Würl Peter, Müller Thomas H, Knippschild Uwe, Henne-Bruns Doris, Breitenstein Stefan, Clavien Pierre-Alain, Graf Rolf, Bond Gareth L, Grochola Lukasz F

Abstract excerpt

PURPOSE: Although pancreatic ductal adenocarcinoma (PDAC) is an aggressive tumor, like other common cancers, it displays a wide range of biology. However, at present, there are no reliable tests to predict patients' cancer-specific outcomes and guide personalized treatment decisions. In this study, we aim to identify such biomarkers in resectable PDAC by studying SNPs in the CD44 gene, which drives the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Pancreatic Ductal

Share to Disease Progression

Share to Gene Expression Regulation, Neoplastic

Share to Hyaluronan Receptors

Share to Pancreatic Neoplasms

Share to Proportional Hazards Models

Source

Identifiers

PMID: 27283965
DOI: 10.1158/1078-0432.CCR-16-0058

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CD44 SNPrs187115: A Novel Biomarker Signature that Predicts Survival in Resectable Pancreatic Ductal Adenocarcinoma.PMID 27283965Read ↗

Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic VariantsSemantic proximity Read ↗

Prospective validation of a predictive non-invasive SNP-based biomarker signature in resectable pancreatic cancer: a study protocolSemantic proximity Read ↗

Pancreatic cancer survival analysis defines a signature that predicts outcomeSemantic proximity Read ↗

A Predictive Noninvasive Single-Nucleotide Variation-Based Biomarker Signature for Resectable Pancreatic Cancer: Protocol for a Prospective Validation Study.Semantic proximity Read ↗

Meta-analysis of 1,200 transcriptomic profiles identifies a prognostic model for pancreatic ductal adenocarcinomaSemantic proximity Read ↗

Clinicopathological and prognostic value of CD44 gene polymorphism (rs187115) in Swedish patients with colorectal cancer.Semantic proximity Read ↗

Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patients.Semantic proximity Read ↗

Genome-wide association study of survival in patients with pancreatic adenocarcinoma.Semantic proximity Read ↗

A replication study and genome-wide scan of single-nucleotide polymorphisms associated with pancreatic cancer risk and overall survival.Semantic proximity Read ↗

Validation of a targeted next-generation sequencing panel for pancreatic ductal adenocarcinomas.Semantic proximity Read ↗

Genetic polymorphisms associated with pancreatic cancer survival: a genome-wide association study.Semantic proximity Read ↗

Genome-wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibility.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.